Objective: To examine unannounced telephone pill counts as a measure of adherence to antiretroviral therapy among adolescents and young adults living with perinatal HIV infection. Methods: Participants were recruited from an ongoing longitudinal study to complete four monthly, unannounced telephone pill counts. Detailed notes concerning participants' medication habits surrounding adherence were recorded. Results: Two-thirds of 102 eligible participants aged 18-27 years participated; 57% were female, 69% were Black. Blacks and participants with viral loads >40 and >1,000 copies/ml were less likely to participate. Average adherence across calls was 77%. Those who completed all calls averaged significantly higher adherence scores than those who did not. Calls revealed adherence barriers at individual (e.g., medication disorganization), social (e.g., limited support), and system (e.g., pharmacy problems) levels. Conclusions: Despite challenges, this procedure can be implemented with this population and can help identify adherence barriers important for interventions that address medication-taking behaviors.
Objective: To examine unannounced telephone pill counts as a measure of adherence to antiretroviral therapy among adolescents and young adults living with perinatal HIV infection. Methods:Participants were recruited from an ongoing longitudinal study to complete four monthly, unannounced telephone pill counts. Detailed notes concerning participants' medication habits surrounding adherence were recorded. Results: Two-thirds of 102 eligible participants aged 18-27 years participated; 57% were female, 69% were Black. Blacks and participants with viral loads >40 and >1,000 copies/ml were less likely to participate. Average adherence across calls was 77%. Those who completed all calls averaged significantly higher adherence scores than those who did not. Calls revealed adherence barriers at individual (e.g., medication disorganization), social (e.g., limited support), and system (e.g., pharmacy problems) levels. Conclusions: Despite challenges, this procedure can be implemented with this population and can help identify adherence barriers important for interventions that address medication-taking behaviors.
Authors: Ann Usitalo; Erin Leister; Katherine Tassiopoulos; Susannah Allison; Kathleen Malee; Mary E Paul; Renee Smith; Russell B Van Dyke; George R Seage; Claude A Mellins Journal: AIDS Care Date: 2013-06-26
Authors: D Shaffer; P Fisher; M K Dulcan; M Davies; J Piacentini; M E Schwab-Stone; B B Lahey; K Bourdon; P S Jensen; H R Bird; G Canino; D A Regier Journal: J Am Acad Child Adolesc Psychiatry Date: 1996-07 Impact factor: 8.829
Authors: Jerry L Grenard; Brett A Munjas; John L Adams; Marika Suttorp; Margaret Maglione; Elizabeth A McGlynn; Walid F Gellad Journal: J Gen Intern Med Date: 2011-05-01 Impact factor: 5.128
Authors: Shoshana Y Kahana; Maria Isabel Fernandez; Patrick A Wilson; Jose A Bauermeister; Sonia Lee; Craig M Wilson; Lisa B Hightow-Weidman Journal: J Acquir Immune Defic Syndr Date: 2015-02-01 Impact factor: 3.731
Authors: Sulachni Chandwani; Linda J Koenig; Anne M Sill; Susan Abramowitz; Latoya C Conner; Lawrence D'Angelo Journal: J Adolesc Health Date: 2012-03-03 Impact factor: 5.012
Authors: Shoshana Y Kahana; Richard A Jenkins; Douglas Bruce; Maria I Fernandez; Lisa B Hightow-Weidman; Jose A Bauermeister Journal: PLoS One Date: 2016-04-01 Impact factor: 3.240
Authors: Emily A Kendall; Betina Durovni; Neil A Martinson; Solange Cavalacante; Katlego Masonoke; Valeria Saraceni; Limakatso Lebina; Anne Efron; Silvia Cohn; Sandy Chon; Richard E Chaisson; David W Dowdy; Jonathan E Golub Journal: AIDS Date: 2020-01-01 Impact factor: 4.632